Media Coverage

The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.

  • Chicago Tribune

    A post-holiday COVID-19 surge? Nothing significant seen yet in Illinois, but experts still wary.

    “It’s still early days, and we’re not out of the woods, even though I don’t think we see anything conclusive in the data yet,” said Jaline Gerardin, a Northwestern University assistant professor of preventive medicine who works on virus modeling.

  • USA Today

    COVID-19 vaccine rollout shouldn’t sacrifice equity for efficiency

    For most of the COVID-19 pandemic, there has been disagreement on every aspect of public health policies (e.g., universal lockdown, school reopenings). But there is near complete agreement that the path forward to end the pandemic is through rapid and mass vaccination to achieve herd immunity.

  • Chicago Tribune

    Illinois confirms first case of more contagious COVID-19 variant as restrictions eased in some regions; Phase 1b of vaccination plan set to start Jan. 25

    The SARS-CoV-2 variant B.1.1.7, which first cropped up in the United Kingdom, was identified by Northwestern University’s Feinberg School of Medicine during an analysis of samples from positive COVID-19 tests, officials said.

  • Crain’s Chicago Business

    New COVID variant detected in Chicago

    The new COVID variant first detected in the U.K. has made its way to Chicago. Chicago and Illinois public health departments today announced that the case was identified through an analysis of positive COVID tests by Northwestern University’s Feinberg School of Medicine.

  • HealthDay

    Aphasia Affects Brain Similar to Alzheimer’s, But Without Memory Loss

    “While we knew that the memories of people with primary progressive aphasia were not affected at first, we did not know if they maintained their memory functioning over years,” said study author Dr. M. Marsel Mesulam, director of the Center for Cognitive Neurology and Alzheimer’s Disease at Northwestern University Feinberg School of Medicine in Chicago.

  • CNN

    As sites shift from COVID-19 testing to vaccinations, health officials warn balance is needed

    From a public health perspective, “testing is necessary in the short-term to be able to react quickly when cases are increasing and prevent or interrupt outbreaks whereas vaccinations are a prophylactic solution to prevent cases and end the pandemic,” said Dr. Sadiya Khan, assistant professor of preventive medicine in epidemiology at Northwestern University Feinberg School of Medicine.

  • MSN.com

    Here’s How Vaccine Rollout Might Impact When The Pandemic Actually Ends

    Some good news is that vaccines are already being distributed to high priority groups and, with that, people should develop immunity to the virus. But even so, we could be doing this weird version of reality for a while, says Clyde Yancy, MD, vice dean for diversity and inclusion at Northwestern Medicine. “Every prediction that anyone might say would be a rough approximation—from me included,” he says.

  • U.S. News & World Report

    Research Reveals Why COVID Pneumonia Is More Deadly

    “Our goal is to make COVID-19 mild instead of severe, making it comparable to a bad cold,” study co-author Dr. Scott Budinger said in the news release. He is chief of pulmonary and critical care medicine at Northwestern University Feinberg School of Medicine. Study co-author Dr. Richard Wunderink, professor of pulmonary and critical care medicine at Feinberg and medical director of Northwestern Medicine’s ICU, added that “this effort truly represents a ‘moonshot’ in COVID-19 research.”

  • Los Angeles Times

    Coronavirus Today: Masking up at home

    Here’s an example I ran by Dr. Marc Sala, a critical care and pulmonary specialist at Northwestern University Feinberg School of Medicine: A vaccinated person could be exposed to someone infected with the coronavirus. The virus might hang out in their respiratory tract for a period of time as it tries — and, due to the vaccine, likely fails — to get a better foothold in their system. During that time, they could potentially transmit the virus to another person, who might go on to develop COVID-19.

  • MSN

    Study aims to enhance prevention of peanut allergy in youth

    “Through supporting pediatric clinicians in adhering to the guidelines, we have an achievable way to prevent peanut allergy and reduce incidence, which is exciting,” Dr. Ruchi Gupta, the study principal investigator, noted.